Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa
- PMID: 11873008
- DOI: 10.1097/00002030-200203080-00016
Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa
Abstract
Objective: To assess the 24 month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission (MTCT) of HIV-1 in a breastfeeding population in West Africa.
Methods: Data were pooled from two clinical trials: DITRAME-ANRS049a conducted in Abidjan, Côte d'Ivoire and Bobo-Dioulasso, Burkina-Faso and RETRO-CI, conducted in Abidjan. Between September 1995 and February 1998, consenting HIV-1-seropositive women were randomly assigned to receive zidovudine (300 mg) or placebo: one tablet twice daily from 36-38 weeks' gestation until delivery, then in DITRAME only, for 7 more days. Paediatric HIV-1 infection was defined as a positive HIV-1 polymerase chain reaction, or if aged > or =15 months, a positive HIV-1 serology. Cumulative risks (CR) of infection were estimated using a competing risk approach with weaning as a competing event.
Results: Among 662 live-born children, 641 had at least one HIV-1 test. All but 12 children were breastfed. At 24 months, overall CR of MTCT were 0.225 in the zidovudine and 0.302 in the placebo group, a 26% significant reduction. Among children born to women with CD4 cell counts < 500/ml at enrollment, CR of MTCT were similar, 0.396 in the zidovudine and 0.413 in the placebo group. Among children born to women with CD4 cell counts > or =500/ml, CR of MTCT were 0.091 in the zidovudine and 0.220 in the placebo group, a significant 59% reduction.
Conclusion: A maternal short-course zidovudine regimen reduces MTCT of HIV-1 at age 24 months, despite prolonged breastfeeding. However, efficacy was observed only among women with CD4 cell counts > or =500/ml. New interventions should be considered to prevent MTCT, especially for African women with advanced HIV-1 immunodeficiency.
Similar articles
-
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Cochrane Database Syst Rev. 2011. PMID: 21735394 Review.
-
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Cochrane Database Syst Rev. 2010. PMID: 20238370 Review.
-
Postnatal transmission of HIV-1 after a maternal short-course zidovudine peripartum regimen in West Africa.AIDS. 2003 Jul 4;17(10):1493-501. doi: 10.1097/00002030-200307040-00010. AIDS. 2003. PMID: 12824787 Clinical Trial.
-
6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mère-Enfant.Lancet. 1999 Mar 6;353(9155):786-92. doi: 10.1016/s0140-6736(98)11046-2. Lancet. 1999. PMID: 10459959 Clinical Trial.
-
Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial.Lancet. 1999 Mar 6;353(9155):781-5. doi: 10.1016/S0140-6736(98)10412-9. Lancet. 1999. PMID: 10459958 Clinical Trial.
Cited by
-
Optimizing infant HIV diagnosis with additional screening at immunization clinics in three sub-Saharan African settings: a cost-effectiveness analysis.J Int AIDS Soc. 2021 Jan;24(1):e25651. doi: 10.1002/jia2.25651. J Int AIDS Soc. 2021. PMID: 33474817 Free PMC article.
-
Cost-effectiveness of integrating postpartum antiretroviral therapy and infant care into maternal & child health services in South Africa.PLoS One. 2019 Nov 15;14(11):e0225104. doi: 10.1371/journal.pone.0225104. eCollection 2019. PLoS One. 2019. PMID: 31730630 Free PMC article.
-
A threshold delay model of HIV infection of newborn infants through breastfeeding.Infect Dis Model. 2019 May 16;4:188-214. doi: 10.1016/j.idm.2019.05.001. eCollection 2019. Infect Dis Model. 2019. PMID: 31194190 Free PMC article.
-
Optimal breastfeeding durations for HIV-exposed infants: the impact of maternal ART use, infant mortality and replacement feeding risk.J Int AIDS Soc. 2018 Apr;21(4):e25107. doi: 10.1002/jia2.25107. J Int AIDS Soc. 2018. PMID: 29667336 Free PMC article.
-
The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis.PLoS Med. 2017 Nov 21;14(11):e1002446. doi: 10.1371/journal.pmed.1002446. eCollection 2017 Nov. PLoS Med. 2017. PMID: 29161262 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials